Medicine and Dentistry
Prostate Cancer
85%
Neuroendocrine Differentiation
33%
Androgen Receptor
19%
Bone Metastasis
18%
Androgen
15%
Androgen Deprivation Therapy
14%
Cancer Cell
14%
Metastatic Carcinoma
13%
Castration Resistant Prostate Cancer
11%
Neoplasm
10%
Epidermal Growth Factor Receptor
10%
Leukemia Inhibitory Factor Receptor
10%
microRNA
10%
Tumor Microenvironment
10%
Leukemia Inhibitory Factor
9%
Mesenchymal-Epithelial Transition
9%
down Regulation
8%
Carcinogenesis
7%
Malignant Neoplasm
7%
Immunosuppressive Treatment
7%
microRNA 1
6%
Bladder
6%
Interferon Alfa
6%
Medicine
6%
Signal Transduction
6%
Progenitor Cell
6%
Chemokine Receptor
6%
Immunosuppressive Drug
6%
Biological Marker
5%
Tumor Suppressor Protein
5%
Disease
5%
In Vitro
5%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Androgen Receptor
32%
Bone Metastasis
21%
Androgen
21%
Epidermal Growth Factor Receptor
20%
Castration Resistant Prostate Cancer
15%
Malignant Neoplasm
14%
microRNA 1
13%
microRNA
11%
Metastasis
9%
Neoplasm
9%
Cancer Growth
8%
Protein Tyrosine Kinase Inhibitor
7%
Tumor Suppressor Protein
6%
Biological Marker
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
33%
Androgen Receptor
26%
MicroRNA
23%
Epidermal Growth Factor Receptor
20%
Promoter Region
16%
Mesenchymal-Epithelial Transition
15%
Signal Transduction
10%
Carcinogenesis
10%
Leukemia Inhibitory Factor Receptor
10%
Upregulation
10%
Transcription Factors
10%
Leukemia Inhibitory Factor
9%
Muscarinic Acetylcholine Receptor
7%
Chemokine
7%
Tyrosine Kinase Inhibitor
7%
Gene Expression
7%
down Regulation
6%
Pyruvate Kinase
6%
Synapsin I
6%
Metabolic Pathway
5%
Cell Proliferation
5%
Cancer Stem Cell
5%